Organic Corrosion Inhibitors 2021
DOI: 10.1002/9781119794516.ch13
|View full text |Cite
|
Sign up to set email alerts
|

Chemical Medicines as Corrosion Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 101 publications
0
0
0
Order By: Relevance
“…Therefore, the implementation of the ambroxol derivative allows to achieve the comparable values of inhibition efficiencies with those of underivatised ambroxol, but using the 30-40 times less concentrated inhibitor solution. This confirms the fact [8] that the chemical modification of pharmaceuticals improves their inhibitory properties. The availability of the source reagents (ambroxol and salicylaldehyde) and the simple synthesis protocol make the compound 2-(6,8-dibromo-3-(4-hydroxycyclohexyl)-1,2,3,4-tetrahydroquinazolin-2yl)phenol a prospective corrosion inhibitor for industrial use.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…Therefore, the implementation of the ambroxol derivative allows to achieve the comparable values of inhibition efficiencies with those of underivatised ambroxol, but using the 30-40 times less concentrated inhibitor solution. This confirms the fact [8] that the chemical modification of pharmaceuticals improves their inhibitory properties. The availability of the source reagents (ambroxol and salicylaldehyde) and the simple synthesis protocol make the compound 2-(6,8-dibromo-3-(4-hydroxycyclohexyl)-1,2,3,4-tetrahydroquinazolin-2yl)phenol a prospective corrosion inhibitor for industrial use.…”
Section: Discussionsupporting
confidence: 82%
“…One of the active pharmaceutical ingredients, in which inhibitory activity on the corrosion of stainless steel in the acidic medium was already demonstrated [5][6][7], is ambroxol. Moreover, it was already shown [8,9] that the chemical modification of different pharmaceuticals might improve their inhibitory properties, and the usage of derivatised pharmaceutical ingredients is also a prominent research field. In the literature, there are several pieces of evidence [10] that the products of condensation of aromatic primary amines with aromatic aldehydes exhibit excellent inhibitory properties.…”
Section: Introductionmentioning
confidence: 99%